- Home
- HUIZ vs ATNM Comparison
HUIZ vs ATNM Comparison
Compare HUIZ & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HUIZ | ATNM |
|---|---|---|
| Founded | 2006 | 2000 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.5M | 36.8M |
| IPO Year | 2019 | 2013 |
Fundamental Metrics
Financial Performance| Metric | HUIZ | ATNM |
|---|---|---|
| Price | $1.80 | $1.15 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $2.30 | ★ $4.00 |
| AVG Volume (30 Days) | 5.6K | ★ 104.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 30.60 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $81,000.00 |
| Revenue This Year | $22.67 | N/A |
| Revenue Next Year | $8.55 | N/A |
| P/E Ratio | $7.81 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.50 | $1.02 |
| 52 Week High | $4.16 | $1.95 |
Technical Indicators
Market Signals| Indicator | HUIZ | ATNM |
|---|---|---|
| Relative Strength Index (RSI) | 44.30 | 48.25 |
| Support Level | $1.60 | $1.02 |
| Resistance Level | $2.19 | $1.25 |
| Average True Range (ATR) | 0.10 | 0.06 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 47.57 | 38.71 |
Price Performance
Historical ComparisonAbout HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.